BioWorld

Nov. 8, 2006

View Archived Issues

Inovio, Wyeth Enter Potential $64.5M Pact On Drug Delivery

Wyeth juiced Inovio Biomedical Corp.'s bottom line with a potential $64.5 million, nonexclusive licensing deal that gives the pharma giant rights to use MedPulser electroporation delivery technology in DNA vaccines. (BioWorld Today) Read More

Pharma Growing Biologics Work To Supplement Small Molecules

Read More

Studying Cell Division, Without Cells, Yields Novel BRCA1 Role

Read More

Cytogen Bringing In $20M For Product Launch, Clinical Work

Read More

Other News To Note

Read More

Clinic Roundup

Read More